4//SEC Filing
Marek David C 4
Accession 0001209191-22-025170
CIK 0001679082other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:25 PM ET
Size
5.2 KB
Accession
0001209191-22-025170
Insider Transaction Report
Form 4
Marek David C
DirectorPrincipal Executive Officer
Transactions
- Sale
Common Shares
2022-04-19$10.45/sh−24,594$257,007→ 447,956 total
Footnotes (2)
- [F1]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
- [F2]The shares were sold at prices ranging from $10.41 to $10.48. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Myovant Sciences Ltd.
CIK 0001679082
Entity typeother
Related Parties
1- filerCIK 0001556914
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 4:25 PM ET
- Size
- 5.2 KB